1. Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Selection of Patients for Long-term Surveillance With Digital Dermoscopy by Assessment of Melanoma Risk Factors Arch Dermatol. 2010;146(3):257-264. doi:10.1001/archdermatol.2009.370 Decision tree for first visit and follow-up examinations. Figure Legend:

2. Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Selection of Patients for Long-term Surveillance With Digital Dermoscopy by Assessment of Melanoma Risk Factors Arch Dermatol. 2010;146(3):257-264. doi:10.1001/archdermatol.2009.370 Distribution of melanomas by risk group. A, Years of follow-up to detect 1 melanoma in a given patient by risk group. B, Percentage of melanomas among all excisions performed within the respective risk groups. C, Number of benign lesions excised because of dynamic changes to detect 1 melanoma. AMS indicates atypical mole syndrome; FAMMM, familial atypical mole and multiple melanoma; and MN, multiple nevi. Figure Legend:

3. Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Selection of Patients for Long-term Surveillance With Digital Dermoscopy by Assessment of Melanoma Risk Factors Arch Dermatol. 2010;146(3):257-264. doi:10.1001/archdermatol.2009.370 Analysis of multiple melanomas and intervals between consecutive melanomas. A, Percentage of patients with melanoma who developed multiple melanomas during the study. B, Mean (SEM) interval between the detection of 2 consecutive melanomas. AMS indicates atypical mole syndrome; FAMMM, familial atypical mole and multiple melanoma; and MN, multiple nevi. Figure Legend:

4. Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Selection of Patients for Long-term Surveillance With Digital Dermoscopy by Assessment of Melanoma Risk Factors Arch Dermatol. 2010;146(3):257-264. doi:10.1001/archdermatol.2009.370 Percentage of melanomas within each risk group that were detected by each examination technique. AMS indicates atypical mole syndrome; FAMMM, familial atypical mole and multiple melanoma; and MN, multiple nevi. Figure Legend: